ロード中...
4CPS-089 All-oral direct-acting antiviral combination therapy: chronic hepatitis c treatment after unsuccessful therapy with daas agents
BACKGROUND: The current standard treatment for patients with chronic hepatitis C virus (HCV) infection is a combination of direct-acting antiviral agents(DAAs). Still, a relatively small amount of patients fail DAAs and there is not enough data to establish treatment recommendations for these cases....
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535271/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.180 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|